VANCOUVER, British Columbia--(BUSINESS WIRE)--ProtoKinetix, Inc. (OTCBB:PKTX) announces new results that add strength to evidence of AAGP™’s powerful anti-inflammatory action. ITTEC Stem’s laboratory has completed a series of tests to determine the anti-inflammatory abilities of AAGP™. The protective qualities of AAGP™ have been well established under a wide variety of hostile stimuli. In the experiments where AAGP™ was NOT present during the radiation treatment, but added AFTER, the results strongly indicate cellular reparation ability.
